# Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease

> **NCT00165737** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 974 (actual)

## Conditions studied

- Dementia, Vascular

## Interventions

- **DRUG:** Donepezil Hydrochloride

## Key facts

- **NCT ID:** NCT00165737
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2005-08
- **Final completion:** 2006-06
- **Target enrollment:** 974 (ACTUAL)
- **Last updated:** 2011-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00165737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00165737, "Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00165737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*